Dark Horse Consulting Group, a leading strategic and operational consulting enterprise in the field of biological therapy (hereinafter referred to as " DHC...
Partnership combines venture creation and biologics discovery to accelerate novel medicines through human clinical proof of concept First-of-its-kind ...
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inha...
Pierre Fabre Pharmaceuticals, Inc. (PFP), announces it has aligned with FDA on a potential path forward for resubmission of the BLA for tabelecleucel, an...
Marks first ENHANZE® agreement to include ADC targets Collaboration also includes option for additional future targets First cl...
De-risking development of genetic medicines through integrated scientific and regulatory leadership with a focus on rare diseases and advanced therapies ...
Members include Nobel laureate James P. Allison, Padmanee Sharma, Taha Merghoub, and Kingston Mills, who are all globally renowned experts in cancer im...
BriaCell Therapeutics Corp. a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care is pleased to announce the a...
Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target approaches Pha...
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma ta...
New collaboration strengthens connections across the global biotech ecosystem Basel Area Business & Innovation, the strategic growth partner helping...
arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced the launch of its immunoMUSE® kits, based on its ...
Hongene Biotech Corporation today announced its support of SiranBio’s SA1211 program, a dual-target siRNA candidate for chronic hepatitis B, unders...
Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology Amgen announced plans to invest an additional $300...
© 2026 Biopharma Boardroom. All Rights Reserved.
